Harsco signs agreement to acquire Clean Earth for $625 million
Category: #business  By Nikita Chaurasia  Date: 2019-05-11
  • share
  • Twitter
  • Facebook
  • LinkedIn

Harsco signs agreement to acquire Clean Earth for $625 million

The acquisition of Clean Earth is expected accretive to earnings in 2020. The companies together are expecting synergies to amount to $10 million by 2020.

Harsco Corporation, the industrial services provider recently announced that it has entered into a definitive agreement for the acquisition of Clean Earth, a leading waste management company in the U.S. The deal was closed for cash transaction of $625 million.

For the record, Clean Earth leads the hazardous waste market and is the largest operator in dredged and contaminated material management market. Operating over 27 permitted facilities in the U.S., the company maintains a portfolio of 200 rare and hard to replicate permits, with a cent percent permit renewal success rate. In 2019, it is expected to generate a revenue of approximately $300 million and $65 million of adjusted EBITDA, cites source. In unison with Clean Earth, Harsco plans to expand its portfolio with a wide range of customized environmental solutions and services.

The Chairman and CEO of Harsco, Nick Grasberger reportedly said that the acquisition is expected to benefit Harsco’s customers and shareholders such as higher profit margins, cost savings, recurring revenues, and potential cross-selling opportunities. Crediting Clean Earth, he further added the strong track-record of growth, safety performance, talented employees and management team is a valuable addition for Harsco.

Grasberger also said that Harsco has been working toward a strategic transformation of its portfolio to create more value for shareholders. The addition of ALTEK Group in May 2018 and the recent acquisition of Clean Earth besides the exit of certain businesses are expected to take Harsco closer to its goal of becoming a global environmental solutions market leader.

Reportedly, Harsco’s strategy will gain hold of large-scale capabilities in the contaminated materials, hazardous waste and dredge material markets, which are complementary to its Metals and Mineral environmental solutions and services offerings.

The acquisition of Clean Earth is expected accretive to earnings in 2020. The companies together are expecting synergies to amount to $10 million by 2020.

 

Source Credit: https://www.globenewswire.com/news-release/2019/05/09/1820551/0/en/Harsco-Enters-Into-Definitive-Agreement-to-Acquire-Clean-Earth-Accelerating-its-Transformation-to-a-Global-Market-Leader-of-Environmental-Solutions.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
By Nikita Chaurasia

Tmunity Therapeutics Inc., a clinical-stage biotherapeutics firm focused on advanced T-cell immunotherapy, has reportedly dosed the first patient in its Phase 1 CART-TnMUC1-01 clinical trial with TnMUC1 (Tn/STn glycoform of mucin 1) CAR-T (chimeric a...

Hyundai and Uber team up to develop all-electric flying taxis
Hyundai and Uber team up to develop all-electric flying taxis
By Nikita Chaurasia

In the midst of technological advancements increasing at a commendable pace, Uber’s flying taxi initiative seems to be edging closer to reality – the reality of establishing flying cars in the near future. The ride-hailing giant has appar...

BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
By Nikita Chaurasia

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical firm leveraging artificial intelligence approaches to advance the next wave of medicines in immuno-oncology and neuroscience, has reportedly announced the initiation of its SERENITY progr...